by Eric Christianson | Oct 28, 2026 | Renal, Urology, and Electrolytes Case Studies
A patient reports increased urinary frequency and incontinence. The response? A new prescription for tolterodine (Detrol). Before adding another medication, pharmacists should consider whether this is a potential prescribing cascade. In a recent case scenario, a...
by Eric Christianson | Oct 25, 2026 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
When we think about medications that cause hyperkalemia (elevated potassium), ACE inhibitors, ARBs, and spironolactone usually come to mind. However, several other medications can increase potassium levels and are easy to overlook in clinical practice. Here are three...
by Eric Christianson | Oct 21, 2026 | Clinical Guideline Updates For Pharmacists, Respiratory Medication and Disease State Clinical Pearls
I’m currently working through some updates to the 2027 study materials! With any All Access pass, you’ll automatically get those updates when they become available in the coming weeks (November-December 2026 timeframe). I wanted to point out one update...
by Eric Christianson | Oct 14, 2026 | Hematology and Immunology Medication and Disease State Clinical Pearls
Azathioprine (podcast) is an immunosuppressant used to treat inflammatory bowel disease, rheumatoid arthritis, lupus, and prevent organ rejection after transplantation. One important safety concern is bone marrow suppression, which can lead to serious infections and...
by Eric Christianson | Oct 11, 2026 | Uncategorized
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as empagliflozin (podcast) (Jardiance) and dapagliflozin (Farxiga), are commonly used to manage type 2 diabetes. These medications can also provide important cardiovascular and kidney benefits. However, increased...
